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INTRODUCTION
In recent years, knowledge of the regulatory molecules that
control the eukaryotic cell cycle has grown dramatically. Two
protein families, Cyclin-dependent serine/threonine kinases
(Cdks) and cyclins, are central components of cell cycle
regulation (reviewed in Pines and Hunter, 1991; Reed, 1992;
Follette and O’Farrell, 1997). The G1 cyclin, Cyclin E, was
shown to be essential and rate limiting for progression into S
phase in Drosophila embryonic and eye imaginal disc cells
(Knoblich et al., 1994; Richardson et al., 1995) and also in
mammalian cells (Ohtsubo, and Roberts, 1993; Resnitzky et
al., 1994; Ohtsubo et al., 1995). We have previously shown that
transcriptional regulation of the Drosophila cyclin E gene
(DmcycE) is an important component in the control of cell
proliferation during Drosophila development. The cycle 17 G1
arrest that occurs in the embryonic epidermal cells prior to
differentiation and the transient G1 arrest of cells in the
morphogenetic furrow of the developing eye disc both require
downregulation of DmcycE (Knoblich et al., 1994; Richardson
et al., 1995). 
Multicellular development requires the coordination of cell
division with morphogenic and developmental processes,
suggesting that cell cycle progression must ultimately be
controlled by developmental regulatory mechanisms. Given
that different tissues exhibit widely variable cell cycle kinetics
and that different regulators such as Dpp, Wingless, Notch and
Prospero are responsible for proliferation or cell cycle arrest in
different developmental contexts (Masucci et al., 1990; Skaer
and Martinez-Arias, 1992; Horsfield et al., 1998; Go et al.,
1998; Richter et al., 1998; Johnston and Edgar, 1998; Li and
Vaessin, 2000; reviewed by Serrano and O’Farrell, 1997;
Myster and Duronio, 2000), it will be important to determine
the nature of the links between developmental regulators and
cell cycle control if we are to understand the cell proliferation
aspects of morphogenesis. 
One mechanism by which developmental signals and cues
could regulate cell proliferation is transcriptional control of cell
cycle regulatory genes. DmcycE is a cell cycle regulatory gene
that could be subject to this method of control, in order to link
S phase with developmental processes during Drosophila
development. The pattern of zygotic DmcycE transcription
during embryonic development is complex and can be divided
into three distinct modes, based on the type of modified cell
cycle that is observed during embryogenesis. 
Zygotic DmcycE transcription is first observed ubiquitously,
at low levels, throughout the epidermis during mitotic cycles
14-16 (Richardson et al., 1993), although all cycles prior to
cycle 17 can occur without zygotic transcription (Knoblich et
al., 1994), presumably due to the presence of maternally
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Cyclin E is an essential regulator of S phase entry. We have
previously shown that transcriptional regulation of the
gene that encodes Drosophila cyclin E, DmcycE, plays
an important role in the control of the G1 to S phase
transition during development. We report here the first
comprehensive analysis of the transcriptional regulation
of a G1 phase cell cycle regulatory gene during
embryogenesis. Analysis of deficiencies, a genomic
transformant and reporter gene constructs revealed
that DmcycE transcription is controlled by a large and
complex cis-regulatory region containing tissue- and stage-
specific components. Separate regulatory elements for
transcription in epidermal cells during cell cycles 14-16,
central nervous system cells and peripheral nervous system
cells were found. An additional cis-regulatory element
drives transcription in thoracic epidermal cells that
undergo a 17th cell cycle when other epidermal cells have
arrested in G1 phase prior to terminal differentiation. The
complexity of DmcycE transcriptional regulation argues
against a model in which DmcycE transcription is regulated
simply and solely by G1 to S phase transcription regulators
such as RB, E2F and DP. Rather, our study demonstrates
that tissue-specific transcriptional regulatory mechanisms
are important components of the control of cyclin E
transcription and thus of cell proliferation in metazoans.
Key words: cyclin E, Cell cycle, Transcriptional regulation,
Drosophila, Development, S phase
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derived products. These embryonic cycles consist of a G2 phase
of variable length, mitosis and an S phase that initiates without
an intervening G1 phase (Edgar and O’Farrell, 1990). Cell
division during these cycles occurs in a complex
spatiotemporal pattern with groups of cells, termed mitotic
domains, undergoing mitosis synchronously (Foe, 1989). The
pattern of S phases, as monitored by bromodeoxyuridine
(BrdU) incorporation, is complex, as a result of the preceding
mitoses. During this period, S phases do not correlate with the
ubiquitous epidermal DmcycE transcription (Richardson et al.,
1993). A similar mode of regulation also appears to operate in
the proliferating cells of the embryonic central and peripheral
nervous systems (CNS and PNS) where cycles lack detectable
G1 phases (Hartenstein et al., 1987; Edgar and O’Farrell, 1990;
Weigmann and Lehner, 1995). Transcription of DmcycE is then
downregulated in most cells by stage 11, close to and perhaps
at the time that cell division ceases after mitosis 16 (Richardson
et al., 1993; Knoblich et al., 1994). Downregulation of DmcycE
expression at this developmental stage is essential for the G1
arrest observed in the epidermis prior to differentiation
(Knoblich et al., 1994). 
A second mode of DmcycE transcription is observed in a
subset of epidermal cells in the lateral thoracic region (thoracic
segments 1, 2 and 3) of the embryo. These cells, here termed
the epidermal thoracic patches, complete a 17th mitotic cell
cycle (Bate and Martinez-Arias, 1991; Knoblich et al., 1994)
and are different to the remainder of the epidermal cells, which
arrest in G1 phase of cell cycle 17. In zygotic null DmcycE
mutants, where maternal sources of Cyclin E become depleted
after cycle 16, the epidermal thoracic patch cells arrest in
G1 phase and do not enter the 17th S phase (Knoblich et al.,
1994), indicating that zygotic DmcycE transcription is essential
for S phase progression in these cells. In addition, ectopic
expression of DmcycE induces all dorsal epidermal cells,
including the epidermal thoracic patch cells, to coordinately
enter S phase, indicating that DmcycE transcription is limiting
for entry of these cells into S phase (Knoblich et al., 1994).
DmcycE transcription is downregulated coordinately in all
epidermal cells, but is activated specifically in the cells of the
thoracic patches in a pattern that precedes the 17th S phase
(Knoblich et al., 1994). Thus the cycle 17 epidermal thoracic
patch cells are the first cells to exhibit G1, S, G2 and M phases
and are the first embryonic cells that are regulated at the G1 to
S phase transition by transcriptional regulation of DmcycE.
The third mode of DmcycE transcription is observed in
endoreplicating tissues such as the gut, where the cell cycle
consists of S phases with intervening gap phases but no mitoses
(Smith and Orr-Weaver, 1991). DmcycE transcription in these
tissues is spatially regulated and coincides with S phase
(Knoblich et al., 1994). The cycling of DmcycE levels in
endoreplicating cells is essential for the rounds of S phases
observed in these cells (Follette et al., 1998; Weiss et al., 1998).
These tissues are further examples of embryonic cells that have
regulated G1 to S phase transitions that are dependent on
DmcycE transcription.
Developmental cues are implicated in the regulation of
DmcycE transcription in Drosophila. For example, in string
(stg) mutant embryos, DmcycE is transcribed in the correct
spatiotemporal pattern and is downregulated at the time when
cycle 17 G1 phase arrest would normally occur, despite the fact
that all cells remain in G2 phase of cycle 14 (Knoblich et al.,
1994). Thus in these cells, DmcycE transcription is
independent of cell cycle progression and must be responding
to developmental cues.
To investigate the relationship between embryonic
development and cyclin E transcriptional control, we have
dissected the DmcycE transcriptional regulatory region using a
combination of DmcycE deficiencies, a genomic transformant
and reporter gene constructs. In this first comprehensive
analysis of developmental transcriptional regulation of a key
G1 phase cell cycle regulatory factor, we show that DmcycE
has a large regulatory region containing multiple tissue-specific
cis-acting sequences that act to coordinate the G1 to S phase
transition with embryonic development.
MATERIALS AND METHODS
Generation of constructs for germline transformation and
generation of transgenic flies
The regions of genomic DNA used in all constructs are summarised
in Fig. 1. The construct used to attempt genomic rescue consists of a
10.7 kb KpnI genomic fragment covering the DmcycE type I transcript
cloned into P{CaSpeR-4} to generate P[w+]TI. Transgenic flies
containing P[w+]TI were obtained by P-element-mediated germline
transformation of w1118 embryos and selection of w+ transgenic flies.
Three independent homozygous viable transformant lines were
obtained and used in further analysis. 
The 1.0TATAlacZ DmcycE promoter-lacZ reporter construct (see
Fig. 1) was made by cloning the 1.0 kb genomic HindIII/EcoRI
fragment upstream of a minimal hsp27 promoter and a nuclear
targeted lacZ (nlacZ) reporter gene (from G. Riddihough). The
assembled DNA was then cloned into the P{CaSpeR-4}
transformation vector and used to transform the germline of flies using
P-element-mediated transformation.
All remaining reporter gene constructs utilised the DmcycE
promoter in place of the hsp27 promoter. An NcoI site was created at
the DmcycE ATG by site-directed mutagenesis. The resulting 2.9 kb
NcoI fragment containing the DmcycE Type I 5 ¢ UTR and proximal
promoter sequences was ligated to the NcoI site corresponding to the
ATG translation start site of nlacZ in a pBluescriptII (Stratagene)
vector to create pBST-2.9lacZ. Constructs used in this study were
derived from pBST-2.9lacZ by sequential addition of DmcycE
genomic fragments. Most of the endogenous promoter constructs
contained contiguous upstream DmcycE genomic sequences from the
Type I DmcycE ATG, the 3.3+1.9lacZ construct being the only non-
contiguous endogenous promoter construct characterised in this study.
Constructs were assembled in pBluescriptII (Stratagene), excised
using KpnI and NotI, cloned into the P{CaSpeR-4} transformation
vector and transgenic flies generated as described above.
Whole-mount RNA in situ hybridisation, bromodeoxyuridine
(BrdU) incorporation and immunohistochemistry
Whole-mount RNA in situ hybridisation to embryos was performed
essentially as described by Tautz and Pfeifle (1989). For DmcycE
RNA in situ hybridisation, lacZ expression from either a CyOwglacZ
or a CyOftzlacZ balancer chromosome was detected by antibody
staining to allow unambiguous identification of the homozygous
DmcycE mutant embryos. For BrdU labelling to detect S phases,
embryos were labelled for 30 minutes with BrdU as previously
described by Richardson et al. (1993). After labelling and fixation of
DmcycE mutations, lacZ expression from either the CyOwglacZ or a
CyOftzlacZ balancer chromosome was used to identify homozygous
mutant embryos, as described above.
All embryos were mounted in 80% glycerol in 1 x PBS and
visualised and photographed on a Zeiss Axiophot microscope using
Nomarski optics.
L. Jones, H. Richardson and R. Saint
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RESULTS
Zygotic DmcycE transcription is controlled by a
large cis-regulatory region 
The DmcycE locus produces two transcripts, Type I and Type
II, from different promoters (Richardson et al., 1993; L. Jones,
M. Silson, W. Winnall, R. Saint and H. E. Richardson,
unpublished). The Type I promoter drives embryonic zygotic
transcription, while the Type II promoter is used to generate
the maternally derived transcripts present in the embryo
(Richardson et al., 1993; D. Crack, J. Secombe, A. Brumby,
M. Coombe, R. Saint and H. E. Richardson, unpublished).
Because of its role in embryonic zygotic DmcycE expression,
the studies described here focus on the regulation of DmcycE
Type I transcription. The extent of the cis-acting regulatory
region controlling zygotic DmcycE (Type I) transcription was
initially investigated by generating transgenic flies carrying a
10.7 kb KpnI genomic DNA fragment that spanned the zygotic
DmcycE transcript (P[w+ TI]) and included approximately 4.8
kb upstream and 1.8 kb downstream of this transcript (Fig. 1).
Two independent transformants homozygous for P[w+ TI]
failed to rescue to viability a DmcycE null allele
(DmcycEAR95) trans-heterozygous with either Df(2L)TE35D-
17 or Df(2L)TE35D-19, two deficiencies that uncover the
DmcycE gene (data not shown; Knoblich et al., 1994).
To determine if the P[w+ TI]
transgene expressed the zygotic
DmcycE transcript during
embryogenesis, whole-mount in situ
hybridisation was carried out on
embryos homozygous for each of
three independent lines of the
transgene in a homozygous DmcycE
deficiency background. In the absence
of the transgene, no transcripts were
detected in post-blastoderm embryos
homozygous for either of the two
DmcycE deficiencies Df(2L)TE35D-
19 or Df(2L)TE35D-17 (Fig. 2C,H
and results not shown). In embryos
homozygous for a DmcycE deficiency
and carrying the P[w+ TI] transgene,
DmcycE transcripts were detected in
epidermal tissues during mitotic
cycles 14-16 (data not shown) and in
the proliferating CNS (Fig. 2B) in a
pattern similar to that observed in
DmcycE+ sibling embryos, which
express DmcycE in a wild-type
pattern (Fig. 2A). The proliferating
PNS cells of P[w+ TI] transgenic,
DmcycE deficient homozygous
embryos also showed DmcycE
expression in a pattern similar to
DmcycE+ siblings, with the exception
of PNS neuroblasts in the maxillary
and labial head segments, in which
DmcycE transcripts were reduced or
absent (Fig. 2B, compare with A). In
addition, DmcycE transcripts from the
transgene were not detectable in the
epidermal thoracic patches (Fig. 2B,B ¢, compare with A,A ¢ ).
The absence of DmcycE expression in the epidermal thoracic
patches correlates with the absence of BrdU incorporation into
these cells in DmcycE deficient embryos carrying the P[w+ TI]
transgene (Fig. 2E, compare with D). Finally, staining in the
endoreplicating gut (Fig. 2F) was not detectable above the
background observed using a cyclin E probe with cyclin E
deficient embryos (Fig. 2G, compare with H). In P[w+ TI]
transgenic DmcycE deficient embryos, expression of DmcycE
correlated with S phases in all tissues, as revealed by BrdU
incorporation (Fig. 2E and data not shown). These data indicate
that the 10.7 kb KpnI genomic fragment could drive DmcycE
expression at sufficiently high levels, in the tissues in which it
is expressed, to induce entry into S phase.
These results demonstrate that the regions covering and
closely flanking the zygotic Type I transcript in the P[w+ TI]
transgene contain cis-acting regulatory sequences that drive
DmcycE transcription in the constitutive epidermal pattern
during mitotic cycles 14-16, in the proliferating CNS and most
of the proliferating PNS. However this pattern of DmcycE
expression represents only part of the wild-type pattern seen
during embryogenesis. The lack of DmcycE transcripts and S
phases in the epidermal thoracic patches and a subset of the
proliferating PNS cells shows that part or all of the cis-acting
sequences regulating DmcycE transcription in these tissues are
Fig. 1. Deficiencies and transformation constructs used in this study: a summary of the
deletions and constructs used. The TI genomic fragment used in the rescue attempt, a series of
P-element excision-derived deficiencies and the genomic fragments used to generate a series of
reporter gene constructs are shown in relation to a genomic map of DmcycE. The broken lines
indicate uncertainties in the position of deficiency breakpoints.
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located outside of the 10.7 kb KpnI region contained in the
P[w+ TI] transgene. The lack of these regulatory elements
provides an explanation for the inability of this transgene to
rescue a DmcycE null mutation. Significantly, these results
indicate that regulation of DmcycE transcription during
embryogenesis is driven by separable tissue-specific cis-acting
regulatory regions.
Identification of cis-acting sequences required for
DmcycE transcription in the epidermal thoracic
patches and the PNS
Three large P-element-mediated deletions DmcycE8L,
DmcycE12L and DmcycE19L (see summary in Fig. 1), which
remove putative cis-acting regulatory sequences important for
zygotic DmcycE transcription during embryogenesis, have been
generated from a lethal P-element insertion allele of DmcycE
(l(2)05278) that appears to specifically disrupt endoreplication
S phases (L. Jones, M. Silson, W. Winnall, R. Saint and H. E.
Richardson, unpublished). Whole-mount in situ hybridisation
analysis of DmcycE8L homozygous mutant embryos (the largest
P-element-induced deletion; Fig. 1) revealed the presence of
DmcycE transcripts in the epidermis and the proliferating CNS
in a pattern similar to wild type, although the overall level of
transcripts detected was reduced when compared with
DmcycE+ sibling embryos (Fig. 3B, compare with A).
However, transcripts were not detected in the proliferating PNS,
nor in the epidermal thoracic patches (Fig. 3B). A similar result
was obtained with homozygous embryos of the second largest
deficiency, DmcycE12L, except that transcripts in the epidermis
and CNS were at wild-type levels (Fig. 3D, compare with C).
DmcycE transcripts were also present in one or two PNS cells
per parasegment in this deficiency, but were not detected in the
thoracic patches (Fig. 3C,D and results not shown). BrdU
incorporation revealed that the distribution of S phases mirrored
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Fig. 2. The 10.7 kb DmcycE genomic transgene does not generate a complete pattern of DmcycE transcripts during embryogenesis. Whole-
mount in situ hybridisation using a DmcycE probe (A-C,F-H), BrdU incorporation (D,E). (A) A stage-11 embryo heterozygous for a DmcycE
deficiency and carrying the transgene, showing normal transcript levels in the CNS, PNS and epidermal thoracic patches. (A¢ ) A higher
magnification of thoracic patch expression in A, showing the epithelial nature of the cells expressing DmcycE. Out-of-focus CNS and PNS cells
lie underneath these cells. (B) A stage-11 embryo homozygous for a DmcycE deficiency and carrying the TI transgene, showing transcripts in
the CNS and PNS, but absence of transcripts in the epidermal thoracic patches and reduced levels of transcripts in the maxillary and labial
neuroblasts. (B ¢ ) A higher magnification of the region that normally shows thoracic patch expression. Expression in CNS and PNS cells
remains. (C) A stage-11 embryo homozygous for a DmcycE deficiency, showing absence of cyclin E transcripts. (D) A late stage-11/early
stage-12 wild-type embryo showing incorporation of BrdU into cells of the thoracic patches and CNS and PNS cells. The arrowhead indicates
an example of a PNS cell that has incorporated BrdU. (E) A late stage-11/early stage-12 embryo homozygous for a DmcycE deficiency and
carrying the TI transgene, showing S phases in the CNS and PNS, but not in the epidermal thoracic patches. (F) A stage-13 embryo
heterozygous for a DmcycE deficiency and carrying the transgene, showing normal transcription in the CNS and endoreplicating gut. The
brown stain in this figure is the result of immunohistochemical staining of b -galactosidase derived from the balancer chromosome. (G) A stage-
13 embryo homozygous for a DmcycE deficiency and carrying the TI transgene, showing transcripts in the CNS but no staining above
background in the endoreplicating gut. (H) A stage-13 homozygous DmcycE deficiency control embryo. cns, central nervous system staining;
mx, maxillary staining; lb, labial PNS staining; tp, thoracic patches.
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the distribution of DmcycE transcripts in homozygous
DmcycE12L embryos (Fig. 3E,F).
Characterisation of embryos homozygous for DmcycE19L,
one of the smallest of the deletions (Fig. 1), revealed the
presence of DmcycE transcripts in the CNS and PNS in a
pattern similar to wild-type embryos, although the level of
DmcycE transcripts in the PNS cells initially appeared to be
less than in heterozygous sibling embryos (Fig. 3H,J, compare
with G,I; data not shown). Interestingly, the DmcycE19L
deletion partially disrupted DmcycE expression in the
epidermal thoracic patches, as only a subset of the thoracic
patch cells of the first thoracic segment expressed DmcycE
(Fig. 3G,G¢, compare with H,H ¢ ), suggesting that these patches
of expression may constitute a complex domain of DmcycE
regulation.
These analyses define the location of separable DmcycE
regulatory elements. Elements essential for DmcycE
transcription in the PNS lie between the 3¢ breakpoints of the
DmcycE19L and DmcycE12L deletions (see Fig. 1), although
other PNS enhancers required for initial maximal expression
lie outside of this region. This region also contains elements
required for a subset of the expression pattern in the epidermal
Fig. 3. Phenotypic analysis of the 8L, 12L and 19L
deficiencies during embryogenesis. Whole-mount
in situ hybridisation using a DmcycE probe 
(A-D,G,G¢ ,H,H¢ ,I,J) and BrdU incorporation 
(E,F). Homozygous embryos were detected by the
absence of ftzlacZ expression, in the case of
B,D,H,J, and by the absence of wglacZ staining in
F. (A-F) Stage-11 embryos. (A) DmcycE+ sibling
of the DmcycE8L embryo in B, showing the wild-
type pattern of transcripts in the CNS, PNS and
epidermal thoracic patches. (B) Homozygous
DmcycE8L embryo showing very reduced levels of
transcripts in the CNS and absence of transcripts in
the PNS and epidermal thoracic patches. 
(C) DmcycE+ sibling of the DmcycE12L embryo in
D showing the wild-type pattern of transcripts in
the CNS, PNS and epidermal thoracic patches. 
(D) Homozygous DmcycE12L embryo showing
transcripts in the CNS, but very reduced PNS
expression and no epidermal thoracic patches
transcripts. (E) BrdU incorporation in a
heterozygous DmcycE12L embryo showing the
wild-type pattern of S phases. wglacZ expression is
detected by the blue staining. (F) BrdU
incorporation in a homozygous DmcycE12L
embryo showing S phases in the CNS, but fewer
S phases in the PNS and no S phases in the
epidermal thoracic patches. (G-H¢ ) Late stage-
11/early stage-12 embryos. (G) DmcycE+ sibling
of the DmcycE19L embryo in H, showing the wild-
type pattern of cyclin E expression. The brown
stain is the result of immunohistochemical staining
of b -galactosidase derived from the balancer
chromosome. (G¢ ) Higher magnification of
thoracic patch expression in G, showing the
epithelial nature of these cells. (H) Homozygous
DmcycE19L embryo showing transcripts in the
CNS and PNS, but fewer cells in the epidermal
thoracic patches expressing DmcycE than in G,
most obviously in the first thoracic segment. 
(H¢ ) Higher magnification of thoracic patch
expression in H showing the epithelial nature of
these cells. (I,J) Early stage-12 embryos. 
(I) DmcycE+ sibling of the DmcycE19L embryo in
J, showing the wild-type pattern of cyclin E
expression. The brown stain is the result of
immunohistochemical staining of b -galactosidase
derived from the balancer chromosome. 
(J) Homozygous DmcycE19L embryos showing
transcripts in the CNS and PNS. cns, central
nervous system staining; pns, peripheral nervous
system staining; mx, maxillary staining; lb, labial
PNS staining; tp, thoracic patches.
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thoracic patches. Regulatory elements that are required for the
complete pattern of DmcycE transcription in the epidermal
thoracic patches are located between the 3 ¢ breakpoints of the
DmcycE19L deletion and a group of small P-element-mediated
deletions represented by DmcycE7L in Fig. 1. Embryos that are
homozygous for these small deletions have a wild-type
DmcycE transcription pattern in the CNS, PNS and the
epidermal thoracic patches (results not shown). The locations
of regulatory elements defined by these deficiencies are
consistent with the locations determined by the analysis of the
P[w+ TI] transgene.
Reporter gene analysis further defines
DmcycE tissue-specific cis-acting
regulatory elements
To confirm and extend the results obtained from
the previous analyses, a series of DmcycE
promoter-lacZ reporter gene constructs
(summarised in Fig. 1) were generated and
introduced into flies using P-element-mediated
germline transformation. All but one of the lacZ
reporter constructs contained the immediate
endogenous zygotic promoter sequences and the
entire DmcycE 5 ¢ untranslated region (UTR)
fused to the ATG of an open reading frame
encoding a nuclear targeted b -galactosidase. The
endogenous DmcycE promoter was favoured
over a heterologous minimal TATA promoter
because zygotic DmcycE transcription is under
the control of a TATA-less promoter (L. Jones,
M. Silson, W. Winnall, R. Saint and H. E.
Richardson, unpublished). The only reporter
gene construct in which a heterologous
promoter was used contained the promoter
proximal 1.0 kb HindIII/EcoRI genomic
fragment joined to the hsp27 TATA box and lacZ sequences
(the 1.0TATAlacZ construct, Fig. 1). With one exception,
embryos homozygous for at least three independent insertions
of each transgene were characterised using whole-mount in
situ hybridisation to determine the pattern of lacZ reporter
gene transcription. The exception was the 16.4lacZ
construct, where only one line was characterised. The
activity of this transformant was assumed to be unaffected by
local chromosome position effects, as the lacZ expression
patterns produced were consistent with those of other
constructs.
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Fig. 4. DmcycE cis-acting elements that regulate
expression in the CNS and epidermis during
embryogenesis. Whole-mount in situ hybridisation
using a DmcycE or lacZ reporter gene probe as
indicated. (A-D) Stage 5-6 embryos. (A) w1118
embryo, DmcycE probe; (B) 1.0TATAlacZ embryo,
lacZ probe; (C) 1.2lacZ embryo, lacZ probe; 
(D) 1.9lacZ embryo, lacZ probe. (E,F) Late stage-9
embryos. (E) w1118 embryo, DmcycE probe, showing
general epidermal expression of DmcycE. (F) 1.9lacZ
embryo, lacZ probe, showing general epidermal
expression of the lacZ reporter gene. (G,H) Stage-11
embryos. (G) w1118 embryo, DmcycE probe; 
(H) 1.0TATAlacZ embryo, lacZ probe. Note the lack of
PNS and epidermal thoracic patch transcripts. 
(I-L) Late stage-11 embryos. (I) w1118 embryo,
DmcycE probe. Note that epidermal thoracic patch
staining has gone by this stage; (J) 1.0TATAlacZ
embryo, lacZ probe showing a few faintly stained PNS
cells indicated by arrowheads; (K) 1.2lacZ embryo,
lacZ probe; (L) 1.9lacZ embryo, lacZ probe. 
(M,N) Stage-13 embryos. (M) w1118 embryo, DmcycE
probe; (N) 1.0TATAlacZ embryo, lacZ probe. Note the
absence of transcripts in the endoreplicative gut. CNS,
central nervous system; PNS, peripheral nervous
system; tp, thoracic patch; amg, anterior midgut; pmg,
posterior midgut; hg, hindgut.
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CNS and early epidermal expression
The 1.0TATAlacZ heterologous promoter construct and the
1.9lacZ endogenous promoter construct extend the same
distance 5 ¢ from the start of zygotic DmcycE transcription (Fig.
1). The patterns of lacZ transcripts derived from these two
constructs are essentially identical (Fig. 4 and data not shown),
indicating that there was no obvious difference between the
endogenous DmcycE and heterologous hsp27-TATA promoters. 
Expression of the lacZ reporter gene from the 1.0TATAlacZ
and 1.9lacZ endogenous promoter constructs was detected in
the early epidermis (Fig. 4A,B,D-F) and also in the
proliferating CNS (Fig. 4G-J,L-N) in a pattern similar to that
normally seen for DmcycE. This indicates that cis-acting
sequences required for driving DmcycE transcription in the
epidermis during cycles 14-16 and in the CNS cells are located
within this 1.0 kb fragment. Significantly, epidermal reporter
gene expression was downregulated by the end of stage 11
(Fig. 4J,L, compare with G), suggesting that the sequences
driving expression of the reporter constructs include the
regulatory elements responsible for the downregulation of
wild-type DmcycE.
In contrast to the normal pattern of epidermal and CNS
expression from the 1.0TATAlacZ and 1.9lacZ constructs, there
was a dramatic absence of lacZ transcripts in most of the
proliferating PNS cells. Very low levels of lacZ expression
were detected in one or two PNS cells per segment (Fig. 4G-
J,L). This result is consistent with analysis of the DmcycE12L
regulatory region deletion (see above) and indicates that
DmcycE transcription in the CNS and PNS cells is regulated
by different cis-acting sequences. In addition, lacZ transcripts
Fig. 5. DmcycE cis-acting elements that regulate expression in the PNS and epidermal thoracic patches. Whole-mount in situ hybridisation using
a lacZ probe in stage-11 embryos (A-F). (A) 5.5lacZ embryo showing expression in the CNS and PNS cells; (B) 13.2lacZ embryo showing
expression in the CNS and PNS cells; (C) 16.4lacZ embryo showing expression in the CNS and PNS cells; (D) higher magnification of the
5.5lacZ embryo shown in A. Expression is absent in the neuroblasts of the maxillary and labial segments as well as in the epidermal thoracic
patches. (E) Higher magnification of the 13.2lacZ embryo shown in B, exhibiting expression in the CNS and PNS cells, including the neuroblasts
of the maxillary and labial segments and expression in epidermal thoracic patch cells. (F) Higher magnification of the 16.4lacZ embryo shown in
C, exhibiting expression in the CNS and PNS cells, including the neuroblasts of the maxillary and labial segments and expression in epidermal
thoracic patch cells. (G-I) Late stage-11 embryos. (G) 5.5lacZ embryo showing absence of expression in the posterior spiracle primordium; (H)
13.2lacZ embryo showing expression in the posterior spiracle primordium; (I) 16.4lacZ embryo showing expression in the posterior spiracle
primordium. (J-L) Stage-12 embryos. (J) 5.5lacZ embryo showing expression in the CNS and PNS cells; (K) 13.2lacZ embryo showing
expression in the CNS and PNS cells; (L) 16.4lacZ embryo showing expression in the CNS and PNS cells. See Figs 2, 4 for abbreviations.
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were not detected in the epidermal thoracic patches nor in
endoreplicating tissues (Fig. 4G,H,M,N), suggesting that
essential regulatory sequences controlling DmcycE
transcription in these tissues are located outside of the 1.0 kb
HindIII/EcoRI genomic fragment, again consistent with the
phenotypic analysis of deficiencies and the genomic fragment
described above (summarised in Fig. 7). Consistent with all
necessary epidermal and CNS elements being localised to the
1.0 kb HindIII/EcoRI fragment, all larger constructs containing
this region exhibited expression of lacZ in the epidermis during
mitotic cycles 14-16 and in the proliferating CNS cells (data
not shown).
Embryos homozygous for the 1.2lacZ construct, which
contains approximately the last 400 bp of the 1.0 kb
HindIII/EcoRI fragment, expressed lacZ at a very low level in
both the epidermis and the CNS (Fig. 4C,K). This suggests that
the enhancers necessary for this pattern of DmcycE
transcription are located in this 400 bp fragment. However, as
the level of lacZ transcripts is markedly reduced relative to the
1.0TATAlacZ and 1.9lacZ constructs, regulatory elements that
increase the level of transcription in this pattern must be
located in the remaining 600 bp region of the 1.0 kb
HindIII/EcoRI fragment. 
PNS expression
The 5.5lacZ construct is the smallest endogenous promoter
construct that gave a pattern of lacZ expression in PNS cells
similar to that observed for wild-type DmcycE (Fig. 5A,D,J).
Interestingly, the pattern of PNS lacZ transcripts was not
complete as it lacked expression in PNS neuroblasts of the
maxillary and labial segments (Fig. 5D). This result is
consistent with the pattern of zygotic DmcycE transcription
observed from the 10.7 kb KpnI P[w+ TI] genomic rescue
construct, which extends to the same 5 ¢ KpnI restriction
enzyme site used in the 5.5lacZ construct. The next smallest
endogenous promoter construct, the 2.9lacZ, fails to express
lacZ in the PNS in all but 1 or 2 cells per segment (data not
shown), so the regulatory sequences responsible for driving
DmcycE transcription in proliferating thoracic and abdominal
PNS cells must be located in a 2.6 kb KpnI/NcoI genomic
fragment (summarised in Fig. 7). 
Embryos homozygous for either the 13.2lacZ or the
16.4lacZ endogenous promoter constructs showed lacZ
transcripts in all of the proliferating PNS cells (Fig.
5B,C,E,F,K,L). This pattern was indistinguishable from the
wild-type DmcycE PNS expression pattern, since lacZ
transcripts were now present in the maxillary and labial
segment PNS neuroblasts (Fig. 5B,C,E,F). The detection of
lacZ PNS transcripts in the maxillary and labial head segments
from the 13.2lacZ and 16.4lacZ constructs and the absence of
this pattern from the 5.5lacZ construct indicate that enhancer
sequences necessary for DmcycE transcription in the maxillary
and labial segment PNS cells are located in the 7.7 kb
NheI/KpnI genomic fragment (summarised in Fig. 7). 
Expression in cycle 17 thoracic epidermal cells
lacZ transcripts in the epidermal thoracic patches were
observed in embryos homozygous for the 13.2lacZ and
16.4lacZ promoter constructs (Fig. 5B,C,E,F). The pattern is
similar to wild-type DmcycE transcription in the thoracic
patches in the epidermis of the first and second thoracic
segments. DmcycE expression can also be observed in a small
patch in the ventral epidermis of the third thoracic segment,
but this expression occurs in a much smaller group of cells and
more transiently than in the first and second thoracic patches.
As a result it was very difficult to observe and was not analysed
in detail. As lacZ transcripts in the epidermal thoracic patches
were not observed from embryos homozygous for the 5.5lacZ
construct (Fig. 5A,D), sequences required for driving DmcycE
transcription in the epidermal thoracic patches must be located
within the 7.7 kb NheI/KpnI fragment (see Fig. 7). The location
of this cis-acting regulatory element is consistent with the
analysis of DmcycE transcription in embryos homozygous for
the DmcycE12L regulatory region deletion, which removes this
7.7 kb NheI/KpnI genomic fragment and lacks DmcycE
transcription in the epidermal thoracic patches (see above).
Expression in the posterior spiracle primordia
Stage-11 and -12 embryos express Rnr2 in the posterior
spiracle primordia prior to S phase entry at this stage (Duronio
and O’Farrell, 1995). DmcycE is also expressed in these cells
(data not shown). LacZ transcripts in the posterior spiracle
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Fig. 6. DmcycE cis-acting elements that regulate expression in the
endoreplicative gut. Whole-mount in situ hybridisation using a
DmcycE or lacZ reporter gene probe as indicated, showing reporter
gene expression in an endoreplication domain in the central midgut
driven by sequences more than 12kb 5 ¢ of the transcription start site.
All embryos are shown at stage 13. (A) w1118 embryo, DmcycE
probe; (B) 13.2lacZ embryo, lacZ probe; (C) 3.3+1.9lacZ embryo,
lacZ probe; (D) 16.4lacZ embryo, lacZ probe. CMG, central midgut;
HG, hindgut; CNS, central nervous system.
4627Drosophila cyclin E transcription
primordia were observed in embryos carrying the 13.2lacZ and
16.4lacZ constructs (Fig. 5H,I), but not in embryos carrying
the 5.5lacZ construct (Fig. 5G). This indicates that the
regulatory region responsible for DmcycE expression in the
posterior spiracle primordia is located within the 7.7 kb
NheI/KpnI fragment, the same region that contains the
regulatory sequences required for expression in the epidermal
thoracic patches.
Expression in endoreplicating tissues
Analysis of the series of DmcycE promoter-lacZ reporter
constructs, up to and including the 13.2lacZ construct, failed
to identify the location of any regulatory elements responsible
for driving DmcycE transcription in the endoreplicating tissues
(Figs 4N, 6B; data not shown), indicating that such elements
are located outside of the 13.2kb NheI/NcoI region covered
in this analysis. This conclusion is consistent with our
observations that the 10.7 kb KpnI P[w+ TI] rescue construct
exhibits no detectable DmcycE expression in endoreplicating
cells (see Fig. 2G).
Interestingly, analysis of two DmcycE promoter-lacZ
reporter constructs has identified a 3.3 kb ClaI genomic
fragment that contains regulatory elements important for
transcription in a subset of the endoreplicating midgut.
Embryos homozygous for either the 16.4lacZ construct or the
3.3+1.9lacZ (see Fig. 1), show a low level of lacZ expression
in cells of the embryonic central midgut (Fig. 6C,D), which is
not present in embryos containing the 13.2lacZ construct (Fig.
6B). However, regulatory elements that are required for
DmcycE transcription in the anterior and posterior midgut,
hindgut, salivary glands and Malpighian tubules remain to be
identified. 
DISCUSSION
We have previously shown that regulated DmcycE transcription
is required to maintain the normal pattern of S phases during
Drosophila development (Knoblich et al., 1994; Richardson et
al., 1995; Secombe et al., 1998). However, the mechanism by
which developmental signals and patterning cues are integrated
to coordinate DmcycE transcription could occur in many ways.
For example, DmcycE could be regulated in a relatively simple
manner, with multiple developmental signals inducing the
expression of a common trans-acting factor that acts on a
small number of DmcycE regulatory elements. Alternatively,
developmental regulation of DmcycE transcription may be
more direct, with a complex set of DmcycE cis-regulatory
elements being responsible for integrating developmental
signals and patterning cues. 
The data presented in this study supports the second
hypothesis. Our analyses revealed the presence of multiple
independent tissue-specific regulatory elements acting to
control DmcycE transcription during embryogenesis. These
include (1) at least two different elements required for
expression in different cells of the peripheral nervous system,
(2) an element required for expression in the epidermal cells
and central nervous system and (3) an element required for
expression in patches of thoracic epidermal cells that undergo
a 17th G1 phase-regulated cycle, in the PNS of the labial and
maxillary segments and in the posterior spiracle primordia.
These elements were identified by the presence or absence of
tissue-specific expression in a genomic transformant, in
animals carrying small regulatory region deletions generated
by P-element excisions and in genomic fragment-reporter gene
constructs. The results obtained with each of these different
approaches were consistent with the others in terms of the
location of the different elements. One notable group of
elements that were not fully defined in this study are those
responsible for DmcycE expression in endoreplicating tissues.
Only one element was identified that was responsible for
driving DmcycE transcription in the central midgut.
Presumably elements responsible for regulating the remaining
patterns of DmcycE in embryonic endoreplicating tissues lie
further 5¢ or 3¢ of the genomic regions examined in this study.
Our failure to define more than the one endoreplicative
regulatory sequence is surprising. It is possible that other
regulatory sequences lie outside the region studied, but it is also
possible that identification of these domains may be hampered
by the negative autoregulatory nature of DmcycE expression in
Fig. 7. The DmcycE genomic region and identified
regulatory elements. Diagrammatic representation of
the DmcycE genomic region, summarising the locations
of tissue-specific cis-acting regulatory sequences,
defined in this study, in relation to the DmcycE
transcription unit. Note that this is not a complete map
of the enzymes indicated. Only the NcoI NheI ClaI and
KpnI sites used to generate the constructs are indicated.
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these endoreplication domains (Duronio and O’Farrell, 1995;
Sauer et al., 1995). If the elements carrying the endoreplication
regulatory sequences also carry the autorepression sequences,
expression may be inhibited by the endogenous DmcycE. It
should also be noted that additional complexity is likely to exist
in the regulation of DmcycE transcription. For example,
DmcycE was expressed in a subset of the epidermal thoracic
patch cells in DmcycE19L deficient embryos, indicating that
these patches may themselves be complex domains of DmcycE
transcriptional regulation.
Although our analyses have identified separable tissue-
specific cis-acting elements in the DmcycE regulatory region,
we have yet to elucidate the factors that operate on these
elements to drive DmcycE transcription. Some clues to the
trans-acting factors that could be regulating DmcycE
transcription come from studies of cell cycle control
mechanisms in mammalian cells, where cyclin E
transcriptional regulation also plays an important role in
control of the G1 to S phase transition (Ohtsubo and Roberts,
1993; Resnitzky et al., 1994). A well-established model of
G1 phase transcriptional regulation in mammalian cells
postulates a cascade of events initiated by extracellular growth
factor signalling that leads to activation of the Cyclin D/Cdk4
complex, which in turn phosphorylates the tumor suppressor
Retinoblastoma (Rb), disassociating it from the S phase-
specific transcription factors E2F and DP and allowing
transcription of S phase-specific genes, such as cyclin E
(reviewed in Dyson, 1998). 
In Drosophila, where we have an opportunity to examine
G1 phase-regulatory events within a developmental context,
dE2F and dDP are required for embryonic DmcycE
transcription in endoreplicating tissues, but are dispensable for
DmcycE transcription in the CNS divisions that lack G1 and
G2 phases (Duronio and O’Farrell, 1995; Royzman et al., 1997;
Duronio et al., 1998). It is not known whether dE2F and dDP
are required for DmcycE expression in the early embryonic
PNS and epidermal divisions, because maternal products of
these genes may mask any requirement. Nonetheless, the fact
that these transcription factors are dispensable for DmcycE
transcription in the CNS cells argues against the universality
of the mammalian model of cyclin E regulation by E2F. In
addition, the mammalian model predicts that E2F-dependent
transcriptional regulation of DmcycE in endoreplicating tissues
should be mediated through an E2F/DP responsive element. In
the experiments described here, we have shown that this model
is an oversimplification of DmcycE regulation in Drosophila,
as only one element in the 16 kb analysed was found to drive
DmcycE expression in a subset of endoreplicating tissues. Thus
a minimum of two regulatory elements are required for driving
DmcycE expression in endoreplicating tissues. The fact that
expression of DmcycE in these tissues has been shown to be
dependent on the E2F/DP complex appears at first sight to be
paradoxical. The paradox would be resolved if expression
requires activation by both E2F/DP and tissue-specific
activators. An absolute requirement for a developmental signal
cannot however exist, as ectopic expression of E2F and DP
together induces DmcycE expression in all G1-arrested
epidermal cells (Duronio et al., 1996). It remains possible that
the high levels of E2F and DP expressed following heat shock
induction of the respective transgenes overrides the tissue-
specific regulatory component.
Downregulation of DmcycE transcription during cycle 16 is
essential for cycle 17 G1 arrest in epidermal cells prior to
differentiation (Knoblich et al., 1994). Significantly, the
regulatory element that drives constitutive DmcycE expression
in the epidermal cells during cycles 14-16 showed
transcriptional downregulation, characteristic of wild-type
DmcycE expression. If this downregulation requires active
repression of DmcycE transcription, then the regulatory
sequences necessary for this repression must also be located in
the 1.0 kb regulatory element defined here. Alternatively, the
downregulation could be a consequence of the loss of
activation of DmcycE transcription in the epidermis.
Interestingly, a study by Du and Dyson (1999), revealed that
DmcycE is ectopically expressed in a subset of normally G1-
arrested epidermal cells in embryos that are deficient for RBF
(the Drosophila Rb homolog). However, DmcycE transcription
is initially downregulated normally and a G1 cycle 17 arrest is
established in the absence of RBF. These data suggest that
DmcycE is actively repressed in G1-arrested epidermal cells
and that RBF is required to maintain this repression. Although
dE2F or dDP do not result in ectopic DmcycE transcription in
epidermal cells (Duronio and O’Farrell, 1995; Royzman et al.,
1997; Duronio et al., 1998) a RBF/E2F/DP complex may still
mediate this repression if maternal E2F and DP are not
depleted in the respective mutant embryos at this stage. A
transcriptional repression mechanism of DmcycE at this stage
may also be mediated by the second Drosophila E2F, E2F2,
which has been shown to act as a transcriptional repressor of
S phase genes in tissue culture cells (Sawado et al., 1998).
Alternatively, E2F and/or DP may be needed to activate ectopic
DmcycE expression in the absence of RBF. The initial
mechanism acting to downregulate DmcycE transcription
remains to be determined. Further dissection of this regulatory
element may identify separate activation and repression
sequences.
The regulators of DmcycE transcription in other
developmental contexts may be more difficult to identify, as
many candidate genes may be involved. In some cases it is
possible to suggest the involvement of particular regulatory
genes. For example, the discrete expression of DmcycE in the
epidermal thoracic patches, which undergo a G1-regulated 17th
cell cycle, is much stronger in the first thoracic segment and is
absent in the abdominal segments. The products of the
homeotic genes of the Bithorax and Antennapedia Complexes,
which are key components of anterior/posterior patterning
(Heuer and Kaufman, 1992; Castelli-Gair and Akam, 1995)
are therefore candidate upstream regulators of DmcycE
transcription in this tissue. 
Complex transcriptional regulation of cell cycle
regulatory genes: a common theme?
Our understanding of cell cycle regulation has primarily
derived from the single cell yeast, from cultured cells and from
oocytes or very early embryos in which the complex patterning
of embryogenesis has not yet begun. In contrast, cell cycles in
the embryos of a multicellular organism respond to a variety
of developmental cues that give different tissue types and
different cell cycle kinetics. The significance of the relationship
between embryo patterning and cell cycle control is evident
from the pioneering work of Edgar and O’Farrell (1989, 1990),
in which regulation of the cycles that occur during gastrulation
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and germ band extension in Drosophila embryos was shown to
be mediated by the transcriptional regulation of the string (stg)
mitotic activator gene. This transcriptional regulation is
mediated by the patterning genes active during these stages. 
The stg mitotic inducer gene exhibits a remarkably complex
transcriptional regulatory region that responds to a variety of
patterning genes to control cell cycle progression during early
embryogenesis (Edgar et al., 1994; Lehman et al., 1998). The
analysis of DmcycE regulation presented here offers an
interesting parallel with stg in that both genes exhibit
unexpected complexity in transcriptional regulation. It is
striking that both DmcycE and stg, the first cell cycle regulators
to have their transcriptional regulation examined in a
developmental context, contain tissue-specific regulatory
elements. This indicates that transcriptional regulation is
mediated differently in distinct developmental contexts, such
as during the complex events of gastrulation when cycles 14-
16 occur or during the 17th cycle in cells of the epidermal
thoracic patches. 
Why is DmcycE transcriptional regulation so complex? One
clue comes from the observation that the G1 regulators
cyclin D, cyclin E, Rb and E2F/DP are highly conserved
between insects and mammals, but have no specific orthologs
in yeast (Reed, 1996). Perhaps these genes represent a
specialised mechanism that evolved to deal with G1 phase
regulation in multicellular organisms. Complex transcriptional
regulation of cell cycle genes such as DmcycE may be part of
such a mechanism, which permitted the universal eukaryotic
cell cycle regulatory genes to be brought under the influence
of the more recently evolved transcriptional regulatory
mechanisms operating in different tissues and at different
developmental stages.
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